• LAST PRICE
    1.4500
  • TODAY'S CHANGE (%)
    Trending Down-0.0200 (-1.3605%)
  • Bid / Lots
    1.4400/ 1
  • Ask / Lots
    1.4600/ 253
  • Open / Previous Close
    1.4400 / 1.4700
  • Day Range
    Low 1.4100
    High 1.4600
  • 52 Week Range
    Low 0.4986
    High 1.9140
  • Volume
    552,168
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.47
TimeVolumeSLS
09:32 ET291581.43
09:34 ET12361.43
09:36 ET16381.4295
09:38 ET13001.4299
09:39 ET6271.42
09:41 ET15851.41
09:43 ET26581.435
09:45 ET75971.4425
09:48 ET1001.445
09:50 ET28801.445
09:52 ET10001.4401
09:54 ET5001.4401
09:56 ET8431.4499
09:57 ET10001.445
09:59 ET2001.45
10:01 ET109751.445
10:03 ET2031.445
10:06 ET89061.43
10:08 ET18001.44
10:10 ET8001.4485
10:12 ET21921.4433
10:14 ET38331.4499
10:19 ET1001.445
10:24 ET1001.44
10:26 ET1001.445
10:30 ET19001.4499
10:32 ET4501.445
10:33 ET26561.435
10:35 ET5001.4315
10:39 ET171691.435
10:42 ET6751.43
10:44 ET63661.445
10:46 ET5981.445
10:48 ET4721.45
10:51 ET15001.4499
10:53 ET38641.46
10:55 ET22991.455
10:57 ET1001.45
11:02 ET58821.445
11:04 ET13991.45
11:08 ET59911.455
11:13 ET7801.45
11:15 ET1001.46
11:18 ET6251.4585
11:20 ET20131.45
11:22 ET40851.45
11:24 ET1001.45
11:26 ET2001.445
11:27 ET103311.445
11:29 ET7571.45
11:33 ET125281.44
11:36 ET1001.45
11:38 ET7001.44
11:40 ET6921.45
11:42 ET5001.45
11:47 ET7751.4499
11:49 ET89801.4448
11:51 ET8001.445
11:56 ET3871.45
12:00 ET1001.45
12:03 ET841741.43
12:05 ET98731.425
12:07 ET15771.43
12:09 ET8781.43
12:14 ET33001.43
12:16 ET1421.435
12:18 ET76001.43
12:20 ET19991.44
12:21 ET221881.42
12:23 ET88001.43
12:25 ET1001.4379
12:27 ET18001.4399
12:30 ET7051.4391
12:32 ET1001.435
12:38 ET38341.435
12:39 ET6001.435
12:41 ET11191.4399
12:45 ET25491.4399
12:48 ET1001.4381
12:54 ET1001.44
12:56 ET243751.43
12:57 ET7001.42
12:59 ET6771.43
01:06 ET34961.4204
01:08 ET2001.435
01:12 ET3001.43
01:14 ET1001.43
01:15 ET3001.425
01:19 ET21601.4285
01:21 ET1001.43
01:24 ET11851.43
01:28 ET6001.425
01:30 ET1001.43
01:32 ET2001.425
01:33 ET2001.425
01:35 ET15141.42
01:37 ET1001.43
01:44 ET35381.43
01:46 ET1001.43
01:48 ET20001.4299
01:50 ET6001.425
01:51 ET12991.425
01:53 ET3011.43
01:55 ET3501.4299
02:02 ET2001.43
02:08 ET15061.4284
02:09 ET3511.4277
02:11 ET7981.425
02:18 ET1001.43
02:22 ET50001.4298
02:24 ET1001.425
02:26 ET1001.43
02:31 ET2001.425
02:40 ET1001.43
02:44 ET28111.43
02:47 ET30001.44
02:49 ET109141.435
02:51 ET57301.425
02:54 ET42001.43
02:58 ET115651.44
03:03 ET25001.43
03:05 ET100001.44
03:07 ET12001.43
03:16 ET1001.44
03:20 ET157771.445
03:21 ET1001.445
03:27 ET25401.4489
03:30 ET4661.4457
03:32 ET123941.45
03:34 ET26801.451
03:36 ET6501.45
03:38 ET10331.455
03:39 ET6001.4501
03:41 ET2001.455
03:43 ET6331.455
03:48 ET247701.45
03:50 ET24411.455
03:52 ET18001.45
03:56 ET1131.46
03:57 ET22241.455
03:59 ET44381.45
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSLS
Sellas Life Sciences Group Inc
81.4M
-1.3x
---
United StatesMAIA
Maia Biotechnology Inc
82.1M
-2.5x
---
United StatesANIX
Anixa Biosciences Inc
81.3M
-7.4x
---
United StatesIOBT
IO Biotech Inc
79.1M
-0.7x
---
United StatesBCAB
Bioatla Inc
77.9M
-0.6x
---
United StatesSER
Serina Therapeutics Inc
78.7M
-0.7x
---
As of 2024-06-09

Company Information

SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on the development of novel therapeutics for a range of cancer indications. The Company's product candidates, galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1 (WT1), antigen, and SLS009, a selective small molecule cyclin-dependent kinase 9 (CDK9), inhibitor. GPS is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center (MSK), that targets the WT1 protein, which is present in an array of tumor types. GPS has potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic malignancies and solid tumor indications. The Company is developing SLS009, which is licensed from GenFleet Therapeutics (Shanghai), Inc., for all therapeutic and diagnostic uses in the world outside of Greater China.

Contact Information

Headquarters
7 TIMES SQUARE, SUITE 2503NEW YORK, NY, United States 10036
Phone
646-200-5278
Fax
925-498-7799

Executives

Independent Chairman of the Board
Jane Wasman
President, Chief Executive Officer, Director
Angelos Stergiou
Chief Financial Officer
John Burns
Senior Vice President - Clinical Development
Dragan Cicic
Vice President - Head of Regulatory Affairs, Chemistry, Manufacturing, and Controls (CMC) and Quality
Andrew Elnatan

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$85.5M
Revenue (TTM)
$0.00
Shares Outstanding
57.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.45
EPS
$-1.12
Book Value
$-0.25
P/E Ratio
-1.3x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.